Market closed
Surrozen Inc./$SRZN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Ticker
$SRZN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
41
Website
Surrozen Inc. Metrics
BasicAdvanced
$85M
-
-$21.67
0.69
-
Price and volume
Market cap
$85M
Beta
0.69
52-week high
$14.00
52-week low
$8.84
Average daily volume
14K
Financial strength
Current ratio
5.322
Quick ratio
5.073
Long term debt to equity
-31.057
Total debt to equity
-39.612
Management effectiveness
Return on assets (TTM)
-33.76%
Return on equity (TTM)
-767.91%
Valuation
Price to revenue (TTM)
2.761
Price to book
-1.53
Price to tangible book (TTM)
-1.53
Price to free cash flow (TTM)
-1.666
Growth
Earnings per share change (TTM)
1.61%
3-year earnings per share growth (CAGR)
-13.25%
Surrozen Inc. News
AllArticlesVideos
Insiders Are Loving These 5 Tech and Biotech Stocks
24/7 Wall Street·3 weeks ago
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewsWire·4 weeks ago
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Surrozen Inc. stock?
Surrozen Inc. (SRZN) has a market cap of $85M as of April 26, 2025.
What is the P/E ratio for Surrozen Inc. stock?
The price to earnings (P/E) ratio for Surrozen Inc. (SRZN) stock is 0 as of April 26, 2025.
Does Surrozen Inc. stock pay dividends?
No, Surrozen Inc. (SRZN) stock does not pay dividends to its shareholders as of April 26, 2025.
When is the next Surrozen Inc. dividend payment date?
Surrozen Inc. (SRZN) stock does not pay dividends to its shareholders.
What is the beta indicator for Surrozen Inc.?
Surrozen Inc. (SRZN) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.